Chloé Laurencin

Researcher

Lyon College

faculty

13 h-index 60 pubs 591 cited

Research Areas

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Chloé Laurencin, a faculty member at Lyon College, focuses on neurological disorders, particularly Parkinson's Disease and genetic neurodegenerative diseases. Laurencin's research also encompasses the role of trace elements in health, the therapeutic applications of botulinum toxin, and the effects of heavy metal exposure. Laurencin's primary research interests lie in the mechanisms and treatments of neurological conditions.

Metrics

h-index: 13
Publications: 60
Citations: 591

Selected Publications

Motor complications and postural abnormalities interplay in Parkinson's disease (2025) DOI
Modified Unified Wilson’s Disease Rating Scale — scale presentation and pilot clinimetric testing (2025) DOI
Validation of the French Translation of the Movement Disorder Society Non‐Motor Symptoms Scale ( <scp>MDS</scp> ‐ <scp>NMS</scp> ) in Parkinson's Disease (2025) DOI
A comparison of electrophysiological microrecording versus automatic MR-based segmentation to determine subthalamic nucleus boundaries (2025) DOI
The Spectrum of Neurologic Phenotypes Associated With <scp><i>NUS1</i></scp> Pathogenic Variants: A Comprehensive Case Series (2025) DOI
Neuropathy in <scp>GAA</scp>‐<scp>FGF14</scp> Late‐Onset Cerebellar Ataxia (<scp>SCA27B</scp>): Prevalence and Characteristics (2025) DOI
Deep Brain Stimulation in Classical Galactosemia: A Case‐Report (2025) DOI
Two case reports of RAB39B deletion displaying highly variable parkinsonism (2025) DOI
Deep brain stimulation for severe dystonia associated with Wilson disease: A prospective multicenter meta‐analysis of an N‐of‐1 trial (2024) DOI
Falsely reassuring impedance in a patient with deep brain stimulation: a case report (2024) DOI
Shaping the Future of Neurological Wilson’s Disease Assessment and Monitoring with Novel Digital Biomarkers (P10-3.012) (2024) DOI
Globus Pallidus Lesion With Iron Deposition and Dopaminergic Denervation in a Patient With a Pathogenic <i>SLC6A1</i> Variant (2024) DOI
Altérations du système noradrénergique dans la maladie de Parkinson : une étude combinée en IRM-TEP à la 11C-yohimbine (2024) DOI
Essential Tremor Embarrassment Assessment--French Version (2023) DOI
Quality of life in Essential Tremor Questionnaire--French Version (2023) DOI